DR. DAVID RONALD SQUIRES M.D. NPI 1376520148

NPI Information

  • NPI: 1376520148
  • Provider Name: DR. DAVID RONALD SQUIRES, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3696 WHEELER RD
    AUGUSTA, GA
    ZIP 30909
  • Phone: (706) 736-1830

Map and Directions

Get Directions

NPI Details

DR. David Ronald Squires, M.D. is a hematology and oncology internal medicine in Augusta, GA with 29 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. David Ronald Squires, M.D. NPI is 1376520148. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF UTAH SCHOOL OF MEDICINE
Graduation Year:1997

The provider's business location address is:

3696 WHEELER RD
AUGUSTA, GA
ZIP 30909-520
Phone: (706) 736-1830
Fax: (706) 737-5103

The NPI 1376520148 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Folic acid level, rbc (HCPCS:82747)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
  • Urinalysis, manual test (HCPCS:81002)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Magnesium level (HCPCS:83735)
  • Phosphate level (HCPCS:84100)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Blood test, clotting time (HCPCS:85610)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)

The enumeration date for this NPI number is 12/22/2005 and was last updated on 11/14/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology052835GEORGIAYes
2174400000XSpecialist052835GEORGIANo

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1851030536AMEDICAIDGEORGIA
2004423OTHERGEORGIABLUE CROSS BLUE SHIELD
3G52835MEDICAIDSOUTH CAROLINA
4P00035368OTHERGEORGIARAILROAD MEDICARE
5604802700OTHERGEORGIAUNITED HEALTHCARE

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.